Form 8-K - Current report:
SEC Accession No. 0001232524-25-000051
Filing Date
2025-07-25
Accepted
2025-07-25 16:06:09
Documents
12
Period of Report
2025-07-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K jazz-20250724.htm   iXBRL 8-K 44528
  Complete submission text file 0001232524-25-000051.txt   167630

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20250724.xsd EX-101.SCH 1791
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20250724_lab.xml EX-101.LAB 23507
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20250724_pre.xml EX-101.PRE 13530
15 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20250724_htm.xml XML 2906
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 251151738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)